<?xml version="1.0" encoding="UTF-8"?>
<p>Histological diagnosis was examined after admission for adjuvant treatment in all cases by two pathologists. Thus, the patient underwent radiotherapy for a total dose of 59.4 Gy (1.8 Gy/fraction, five fractions per week) to the operative bed plus a 2 cm margin. The treatment was given with volumetric-modulated arc therapy. The treatment was associated with concomitant and sequential chemotherapy with Temozolomide (
 <xref rid="B3" ref-type="bibr">3</xref>). She maintained a Lansky performance score &gt;70. Following a worsening of symptoms, she was subjected to another MRI scan that showed local recurrence. She underwent a second maximal surgery and began the Procarbazine, Lomustine, and Vincristine regimen (
 <xref rid="B4" ref-type="bibr">4</xref>).
</p>
